Navigation Links
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Date:4/15/2013

New York, NY, April 14, 2013 Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.

In this study of 964 healthy Caucasian men, correcting individual PSA levels for these genetic variants led to an 18.3 percent reduction in the number of men who initially had a measured serum PSA above the biopsy criteria, but whose adjusted PSA fell below the cutoff value. The latter group would have likely undergone what would have been an unnecessary biopsy. Conversely, genetic correction led to PSA levels moving from below threshold to above threshold for 3.4 percent of the men, thus sending out an alert for further investigation.

"If our results are validated, adjustment for the four PSA single nucleotide polymorphisms (SNPs) could potentially prevent up to 15 percent to 20 percent of prostate biopsies. Since it has been estimated that more than 1 million biopsies are performed in the United States annually, this could translate into 150,000 to 200,000 potentially unnecessary biopsies every year," says William J. Catalona, MD, professor of urology at the Feinberg School of Medicine of Northwestern University. In addition to cost savings, fewer biopsies mean fewer adverse outcomes, such as infection, sepsis, and hospitalization.

For 98 percent of the men, genetic adjustment of PSA levels did not change outcome. However, genetic correction was important for the 17 men who were reclassified as no longer meeting biopsy criteria of PSA 2.5 ng/ml or greater and the three whose condition was up classified. The results suggest that traditional single cutoff PSA screening levels of 2.5 ng/ml or greater or 4.0 ng/ml or greater
'/>"/>

Contact: Linda Gruner
jumedia@elsevier.com
212-633-3923
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Personalizing medicine: New American Chemical Society Prized Science video
2. Personalizing biologic treatment to individual patients with rheuatoid arthritis is cost-effective
3. Can Selenium Lower Risk of Advanced Prostate Cancer?
4. Counting copy numbers characterises prostate cancer
5. Prostate cancer treatment study changing the way doctors practice
6. Intermittent Hormone Treatment for Prostate Cancer Not the Best
7. Black Men Often Face Delays in Prostate Cancer Care: Study
8. York scientists discover driving force behind prostate cancer
9. Is Early Baldness in Blacks a Clue to Prostate Cancer?
10. Early-onset baldness in African-American men may be linked to prostate cancer
11. Dennis R. Hill MD Announces Launch of High Dose Rate Brachytherapy of Prostate Cancer Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... Calif., April 17, 2014 By discovering a new ... after a stroke, researchers at UC Irvine and the ... that may limit or prevent stroke-induced brain damage. , ... fourth-leading cause of death and primary reason for disability ... in a stroke and lets blood-borne material into the ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... , MORRISTOWN, N.J., July 27 ... ), a leader in generic and specialty branded pharmaceuticals, announced that ... Officer, has taken a leave of absence from the Company for ... Watson, announced that R. Todd Joyce, Vice President, Corporate Controller and ...
... , , NEW YORK, July ... company developing a minimally invasive drug delivery platform for the regional treatment of ... In addition, the Company reported its financial results for the second quarter ended ... , , Screened 40 Additional Patients ...
... , SWIFTWATER, Pa., July 27 Sanofi ... SNY ), announced today that it has shipped the ... Fluzone vaccine is indicated for active immunization in people 6 months ... subtypes A and type B contained in the seasonal influenza vaccine. ...
... , , ... California Cardiothoracic Surgery Center specializes in cardiothoracic surgery including ... seem like serious symptoms. In fact, most people brush off these ... symptoms can be indications of the need for mitral ...
... , , , , ... AMGN ) reported adjusted earnings per share (EPS) of $1.29 for the ... second quarter of 2008. Adjusted net income increased 6 percent to $1,311 million ... of 2008. , , Total revenue decreased 1 percent during the ...
... , , WASHINGTON, July ... Action, the legislative lobbying arm of Family Research Council, will ... President Obama,s proposed government takeover of the health care system. ... Congressional leaders to discuss the moral, ethical, and financial dangers ...
Cached Medicine News:Health News:Watson CFO Mark W. Durand to Take Leave of Absence 2Health News:Delcath Systems Provides Update on Progress 2Health News:Delcath Systems Provides Update on Progress 3Health News:Delcath Systems Provides Update on Progress 4Health News:Delcath Systems Provides Update on Progress 5Health News:Delcath Systems Provides Update on Progress 6Health News:Delcath Systems Provides Update on Progress 7Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 2Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 4Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 5Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 6Health News:Southern California Surgical Center (heart411.com) Specializes in Mitral Valve Replacement 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 3Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 4Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 5Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 6Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 7Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 8Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 9Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 10Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 11Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 12Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 13Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 14Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 15Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 16Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 17Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 18Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 19Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 20Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 21Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 22Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 23
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... TheraQuest Biosciences, Inc., a clinical stage pain management company today announced ... Vice President, Pharmaceutical Development and General Counsel and Douglas R. Baum ... 2010 , TheraQuest unveiled its analgesic product pipeline and provided a status ... , , ...
... 22 OvaGene Oncology Inc., a biotechnology company specializing in ... announced today the opening of its new clinical and research laboratory ... the central headquarters for operations, research, and molecular clinical lab testing. ... The ...
Cached Medicine Technology:Two Pharmaceutical Executives Join TheraQuest Management Team 2OvaGene Oncology Opens New Innovative Gynecologic Cancer Laboratory and Research Facility 2
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features: Eppendorf "pipette/tip" ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 100-1,000 microliter range....
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,409-7) or contact custom...
Medicine Products: